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Strategies for cancer prevention generally come from observational epidemiology and must include monitoring for the effects of the actions. The
measurement-iterative loop allows us to refine our approach to cancer prevention. When available, clinical trials can also provide strategies for
control. Exposure-specific strategies are described; these are such things as health promotion and behavior modification, legislative approaches,
treatment for addiction, changes in the food supply, chemoprevention, occupational and environmental regulation, immunization, identification of
persons with enhanced genetic susceptibility, and improved surveillance systems. For some exposures such as tobacco, zero exposure is the goal.
For others, prudent avoidance or exposures as low as reasonably achievable are appropriate approaches. Research on how to impact deeply
ingrained lifestyle and cultural factors has high priority. - Environ Health Perspect 103(Suppl 8):313-317 (1995)
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Introduction
In his introductory remarks to this confer-
ence, Dr. Samuel Broder indicated that we
need clinical trials to guide us in our strate-
gies for action. It is clear, however, that we
cannot expect to have clinical trial data to
guide us in all our approaches to the pre-
vention of cancer. We need to combine
data from observational epidemiology with
monitoring of the effect of our actions-
the measurement-iterative loop (Figure 1).
This approach will enable us to take cor-
rective actions when necessary to refine our
approach to cancer prevention.
Tobacco
Tobacco carcinogenesis is well accepted.
Except for a few cancers, we must concen-
trate our efforts on control by a combina-
tion of health promotion and legislative
approaches; approaches must be taken in
concert with approaches to the control of
cardiovascular and chronic respiratory dis-
eases and improved maternal and child
health. Our recent experience in Canada,
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socially unacceptable in the dominant cul-
ture, and trends are in motion that seem
inevitable, although, as Dr. Ernst Wynder
emphasized (1), we still need to better
understand the sociological determinants
ofsmoking (a major research requirement,
especially among children and adolescents),
and how we can effectively intervene.
Additional research is still required into
the determinants of quitting smoking, and
how this may be accelerated in the general
population by public health approaches
that are realistic within the present
financial climate.
Dr. Tracy Orleans emphasized the ap-
proaches to treatment ofnicotine addiction
(2). She urged mandating such treatment
as part ofhealth care reform. Treatment of
nicotine addiction is efficacious, but data
supporting this as a public health rather
than a clinical therapy approach are not
available nor are data on how to prevent
addiction. Previous experience suggests
Researh that clinical approaches are unlikely to be
intervention fully effective at the general population
level because ofimpediments to access,
both psychological and financial, many of
those we might wish to treat. Research into
public health approaches is urgently
required. How can the experience in the
clinical setting be made generally applica-
ble? Dr. Orleans also urged increasing the
'P. excise tax on tobacco (2). The problem in
Canada arose because ofthe lower tobacco
prevention taxation levels in the United States than in
lities. The Canada. We need to develop a North
vith aborigi- American, North American Free Trade
d political Agreement, and, preferably, world-wide
long-term approach to tobacco control. This is a
has become public health policy research issue.
Alcohol
There clearly is a high priority to resolve
the extent that breast cancer is induced by
alcohol, as well as the chemical con-
stituents or types of alcoholic beverages
that increase risk. However, for women as
well as men, moderate drinking (usually
defined as the amount of 1 drink!) appears
to have no adverse effect on life expect-
ancy. Nevertheless, we do not know how
we can advocate no more than 2 drinks a
day (or 14 per week) without risking
increasing the adverse effects in a minority
of all populations (the incipient and actual
alcohol abusers), that has been well
demonstrated to be unusually susceptible
to any action that increases the availability
or social acceptability of alcohol drinking.
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Once again, we need research on the
means to influence beneficially the deter-
minants ofheavy drinking, which takes us
back, as for tobacco addiction, to the wider
social environment.
Diet and Nutrition
Like tobacco, diet is a determinant ofother
chronic diseases, and our prevention strate-
gies must be congruent with those adopted
for them, especially Heart Health initia-
tives. Further, as Dr. Peter Greenwald
reminded us, we need to recognize the
nature ofour changing food supply both in
terms ofwhere natural foods are produced
and to what they are exposed during their
production and in terms ofthe increasing
availability ofmanufactured foods. The lat-
ter often involve substitutions or forti-
fication with substances for which there
may be some nutritional justification but
that may, in fact, eliminate protective fac-
tors in natural foods or introduce new,
unexpected hazards.
A major issue, not explicitly discussed
here, is whether we should concentrate on
etiologic research or whether we can, at
least in part, shift to prevention research
and application. Both types of research
would be facilitated by establishing nutri-
tional centers with mandates to increase
knowledge on diet and cancer (and other
chronic diseases) and to make acceptable
interventions in the population. Many
expert groups feel that there is no alterna-
tive but to attempt to apply what is now
known about cancer prevention and that at
least part ofthe prevention research agenda
in this field must be at the general popula-
tion level. Ifthis is indeed true, then we
must conclude, as for alcohol and tobacco,
that the major public health research need
is to determine how to encourage dietary
modification in the direction almost uni-
formly agreed upon-that fruit and vege-
table consumption should be increased and
excess energy intake discouraged-and to
promote a research strategy that Dr.
Lenore Kohlmeier called the need for
research into food-based intervention in
communities (3). I personally still feel that
the overall evidence for diet and cancer
encourages substituting of saturated and
polyunsaturated by monounsaturated fat.
Both are clearly compatible with Heart
Health initiatives.
However, cancer prevention research in
the diet area is already under way in the
clinical trial mode. Such research implicitly
recognizes that the time relationships for
cancer prevention may be different from
those of cancer prevention. Dr. Kenneth
Carroll many years ago produced evidence
that fat reduction at a later stage of car-
cinogenesis reduces mammary cancer inci-
dence in rats; we need to determine
whether interventions achieve the same
results in humans, by continuing with the
Women's Health Initiative, and also
extending it to men. But I feel that such
approaches need to be combined with
community interventions, especially at
young ages, that combine dietary modifi-
cation with promoting physical activity
and use the measurement-iterative loop
approach as part ofthe strategy. Ifphysical
activity truly confounds the international
correlations of dietary fat with breast
and colon cancer, then we should take
advantage ofthis in our interventions.
Hormones and Medications
The area ofhormones and medications is
one in which there are likely to be trade-
offs between the adverse effects ofcancer
and overall health benefits. For those cir-
cumstances in which hormone use reduces
cancer risk (e.g., combined oral contracep-
tives and endometrial and ovarian cancer),
the benefits clearly outweigh the risks, even
with increases in breast and liver cancer,
except possibly for heavy cigarette smokers.
But for estrogen replacement therapy, we
have incomplete evidence, especially with
regard to lifelong risks and benefits for
noncancer conditions such as those related
to bone and cardiovascular disease, particu-
larly when estrogens are combined with
progestins. As Dr. Malcolm Pike empha-
sized, women must be sufficiently informed
to make their decisions. There is a problem
related to the nature of the information
currently given, however, especially by
some professional groups such as gynecolo-
gists. An important prevention research
issue, therefore, is to develop better mecha-
nisms to understand the overall risks
and benefits.
A prevention trial is under way-the
tamoxifen trial-that asks a valid question
that will give us information on etiology,
but will not necessarily result in a viable
public health intervention. The Women's
Health Initiative will also produce relevant
data, although Dr. Barbara Hulka has reser-
vations about the power ofthis study to be
fully informative in this area (4). Not dis-
cussed was a similar trial offinasteride, an
inhibitor of the enzyme that converts
testosterone to dihydrotestosterone, the
principal androgen responsible for normal
and hyperplastic growth of the prostate
gland. The drug has already been found to
relieve symptoms ofbenign adenomatous
hyperplasia ofthe prostate (BAHP) and to
shrink the prostate gland. Aprevention trial
of 18,000 men, given either finasteride or a
placebo for 7 years and followed for life, is
planned by the National Cancer Institute
(NCI). Given the possible benefit for
BAHP, this could, in practice, have wider
application than tamoxifen amongwomen.
Medications that could induce cancer,
as Dr. Paul Stolley emphasized, may be
difficult to evaluate as to their carcino-
genicity because of the impossibility of
detecting carcinogenic effects in premar-
keting trials and the difficulties associated
with monitoring for carcinogenic effects in
postmarketing surveillance. Risk-versus-
benefit considerations are important with
regard to anticancer drugs, especially as
related to long-term effects in children. For
other agents forwhich long-term follow-up
may not be conducted, drug plans in
health maintenance organizations (and in
Canada, in Saskatchewan) need to be more
effectively utilized to answer some of the
unresolved questions. There are also indi-
cations that some medications such as
aspirin may reduce cancer risk (e.g., ofthe
colon). Given the wide utilization ofthis
drug and its potential utility in reducing
cardiovascular disease events, it is impor-
tant to use the available monitoring
mechanisms to attempt to shed light on
this issue.
Occupational Exposures
It clearly is important to reduce carcino-
genic exposures in occupational environ-
ments. However, recent experience with
occupational electromagnetic fields (EMF)
associations suggests caution in extrapolat-
ing from the occupational to the general
environment. Further, we need to bear in
mind both dose and duration ofexposure
when comparing or combining results of
different studies.
One question to be addressed is the
extent to which the identification and
control of occupational carcinogens has
reduced risk sufficiently and if there are
important risks still to be identified. For
example, the risks of lung cancer among
asbestos-exposed workers appears to be
diminishing. The long duration of the
effects ofoccupational exposures (some-
times into the retirement years) must be
borne in mind in making this assessment.
However, there still are likely to be risks to
be identified, particularly from complex
mixtures ofexposures.
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Prevention of the effects of specific
agents, as in agriculture, is at least in part
dependent on increased understanding of
the ways individuals can reduce their expo-
sures. Once again, we must learn how to
increase understanding on the extent that
exposure can be reduced; this appears to be
another field for behavioral research.
Hazard surveillance activities, therefore, are
still important but must be linked to
research and information dissemination.
We must increase surveillance of docu-
mented cohorts using linkage to cancer
registries and the National Death Index for
end points. Large-scale surveys linked to
industrial hygiene measurements may help
clarify the extent to which we have been
successful in reducing exposures, as well
as provide an important database for
surveillance and monitoring in the future.
Other considerations relate to deter-
mining when information is sufficient to
justify reduction in exposure. The tend-
ency to reduce exposure even when
carcinogenicity has not been established
can be applauded, providing substituting
other potential carcinogens is avoided and
there are no other adverse economic and
potentially health-limiting consequences.
General Environmental
Exposures
It appears clear that we need to clean up
our environment for reasons other than
cancer risk. The methodology to determine
the adverse health effects ofenvironmental
exposures is not well developed, however, so
it might be wise to use less evidence to jus-
tify preventive actions. This makes it criti-
cal to use the measurement-iterative loop
philosophy to evaluate the appropriateness
ofany actions taken. Monitoring should be
adapted to environmental considerations,
with linkages to databases, to determine
the effects ofpopulation interventions.
Human exposure to environmental pol-
lutants occurs through air, water, and the
food chain. It is not clear howmanyofthese
pollutants are carcinogens, as many chemi-
cals have not been fully tested for carino-
genicity. The public tends to support actions
taken to produce cleaner air, purer water,
and noncontaminated food. Whether recent
improvements can be sustained under the
present economic circumstances is uncer-
tain, however. Better information through
careful analysis ofpast trends may help to
reinforce continued, if not expanded,
control efforts. The meta-analysis presented
by Dr. Robert Morris (5) suggests that
chlorination ofraw water has an impact on
bladder cancer and rectal cancer risk.
Chlorination ofthe water supply probably
still has an overall beneficial health effect in
spite of the risk ofcancer. Research into
equally effective and inexpensive means of
securing the same ends is desirable.
The general distribution ofexposures in
the environment and the apparent random
occurrence ofcancer, possibly because of
these exposures, creates severe difficulties
for prevention research. Use ofmolecular
biology advances to permit identification
ofpersons particularly susceptible to these
contaminants together with markers of
exposure may help to identify subpopula-
tions suitable for research that may clarify
the need for intervention.
Dr. HodaAnton-Culver issued a call for
the conversion ofexisting cancer registries
with a multiethnic base population to
Cancer Prevention Research Registries
(CPRR) (6). Many cancer registries already
go some way toward performing this func-
tion. Whether they need to incorporate
data on exposure and host factors as she
suggested, however, is questionable. Link-
age with existing databases (providing
identification data are available) may serve
the same purpose and cost less. A major
problem encountered in building up reg-
istries with extensive baseline information is
the difficulty in securing the required data
in an unbiased way, the possibility that
somevariables could be linked to the cancer
state rather than to etiologic factors, and
confidentiality issues that arise at the time
ofdiagnosis of the cancer. Methodology
development for large-scale data monitor-
ing for cancer prevention purposes is
required. One approach suggested is rou-
tine sampling ofthe at-risk base cohort of
the cancer registry for (exposure to) relevant
exposures. Other information systems that
may already be available, or may be devel-
oped as part ofhealth care reform, should
also be explored for cancer surveillance and
prevention purposes.
Radiation
The range of radiation to which humans
are exposed is very wide, from the ionizing
radiations known to cause cancer to the
nonionizing electrical and magnetic fields
associated with electric power where there
is suspicion of but insufficient biological
data to confirm cancer risk.
Medical radiation may account for
about 1% of cancer deaths, whereas occu-
pational exposure contributes very little to
the total cancer burden. Indoor radon expo-
sure, especially for nonsmokers, is a major
research issue. For smokers, interaction of
radon with tobacco carcinogens is likely.
Also an issue may be toxic waste sites and
waste from nuclear reactors.
In the area of radiological protection,
animal experiments are poor guides to
human risk, so radioepidemiology is criti-
cal. Dose and age at first exposure are
important for some sites. There is some evi-
dence from miners that dose rate for radon
exposure may be important, with reduced
risk per unit ofexposure with high expo-
sure. Arsenic exposure in some mines may
increase risk oflung cancer. Study of the
Chernobyl survivors, as well as other
exposed populations, is still needed to place
risks into better perspective forthe public.
Ultraviolet radiation exposure causes
skin cancer; intense exposure in early life in
genetically predisposed individuals is criti-
cal, especially for malignant melanoma.
Change in behavior, rather than a decline
in ozone, is the principal determinant of
increases in exposure and skin cancer.
Whether it is possible to reverse this trend
is unclear. It is urgent to clarify the role of
using sunscreens versus sun avoidance as
effective and safe public health strategies.
For monitoring purposes, improved effi-
ciency in registration of cancer cases is rec-
ommended, preferably to include some
means of registering nonmelanoma skin
cancers, for which estimates currently are
very imprecise.
The data on electrical and magnetic
fields do not currently justify research on
prevention. Etiologic studies are under
way, however, and the situation may
changewithin the next fewyears.
Infectious Agents
In the absence ofeffective immunization,
reduction in the effect ofoncogenic viruses
requires modification ofhuman behavior,
an approach that may encounter even
greater difficulties than tobacco and diet,
since many viruses (e.g., human papilloma
virus, human immunodeficiency virus,
hepatitis B virus [HBV]) are transported by
sexual reproductive factors in early-life
events. HBV vaccination is expected to
reduce liver cancer, while interaction with
aflatoxin suggests earlier benefit might
accrue from reducing such exposures in
foods. Similar interactions with other envi-
ronmental carcinogens associated with
lifestyle (Epstein-Barr virus and nasopha-
ryngeal carcinoma and putrified foods)
require intervention studies.
Research on immunization, ifsuitable
products become available, must incorporate
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adequate monitoring for adverse effects, a
process that may require changing current
attitudes of at-risk communities toward
anonymity.
Of the bacterial agents, only Helico-
bacterpylori appears to be a potential cause
of cancer of the stomach, although large
bowel flora may be part ofthe causal chain
in the development of colon cancer. On
the assumption that treating H. pylori
infection with antibiotics would reduce the
risk of stomach cancer by 30%, the cost
effectiveness of such an approach seems
high. Dr. Julie Parsonnet suggests the cost
to be $70,000 per year oflife gained com-
pared with $5,000 for mammography and
breast cancer. Clearly, more definitive etio-
logic data are required before screening for
infection and treatment will be justifiable
in North America.
Gender, Ethnicity,
and Environment
Sociological evaluation of cultural differ-
ences that have an impact on acceptance of
cancer prevention interventions requires
further emphasis. Poverty and lifestyle are
likely to be more important than ethnicity,
although genetic differences may be
involved and should not be overlooked.
Indeed, they may be emphasized shortly by
the identification of differing genetically
related susceptibilities to carcinogen-metab-
olizing enzymes that may well vary by eth-
nicity. The environment, both social and
physical, may have an adverse impact on
the effectiveness ofprevention.
Although, in general, we know as much
about cancer prevention in women as in
men, there are obvious gaps in our knowl-
edge such as cancer risk among white
women in certain occupations and minori-
ties in most circumstances. Small numbers
ofsubjects and thus of cancers may pose
difficulties for epidemiologic studies that
require multicenter studies, or special analy-
ses ofsubgroups in many studies followed
bypooled analysis.
Some lifestyle factors recognized as rele-
vant in cancer prevention (e.g., dietary
habit and nonsmoking) may be more
prevalent among certain minority popula-
tions than in the population in general.
There is a need to reinforce such behaviors
in these minority populations and extend
them to the general population.
Genetic Susceptibilities and
Environmental Interactions
Genetic-environmental interactions are
important in cancer etiology and must be
considered in cancer prevention. It seems
likely that all cancers have a genetic basis,
although few of these appear to be trans-
mitted in ways to increase cancer risk (i.e.,
to induce hereditary cancer). In terms of
the genetic changes that underly cancer
induction by environmental factors, there
may be relatively few critical oncogenes and
tumor suppressor genes, so hope is increas-
ing for cancer therapy and for identification
ofmarkers for early detection, although it is
not yet clear whether they actually have a
role in cancer prevention.
p53 (the most important of the tumor
suppressor genes so far identified) may be
relevant in 50% of human cancers.
Inherited abnormalities ofp53 have been
identified in a few families with increased
risk of breast cancer, although p53 does
not seem to have a major role in breast
cancer (abnormalities ofp53 are detectable
only in about 30% ofbreast cancer cases).
It is now clear that discrete mutations of
p53 can be induced by exogenous factors
(e.g., carcinogens such as aflatoxin, ciga-
rette smoke, radon, and vinyl chloride) as
well as by endogenous factors.
For inherited genetic factors, we must
remember that the inherited genes are just
the first hit. The second hit, the process
that starts carcinogenesis, comes from envi-
ronmental factors. Identifying these factors
will probably be facilitated by being able to
identify those women and men at increased
risk in the population, particularly those in
families that appear to be transmitting
particular genetic changes.
Genetic research raises the likelihood
that some day we will be able to identify
persons who are particularly susceptible to
the effects of environmental carcinogens.
Whether such susceptibility will be shown
to be largely inherited or in most instances
acquired is quite uncertain at present even
though the acquired susceptibilities are
shown to have a genetic basis. The suscep-
tibilities so far identified are largely related
to differences between individuals in the
metabolism of carcinogens. These appear
to be particularly important in increasing
risk in those experiencing low levels of
exposure to the carcinogens. Combinations
of genes that influence metabolism are
likely to be shown to be most important.
Genetic screening raises many concerns.
Although those potentially at risk who are
found to be negative to the genetic marker
tested will be reassured, there may be con-
cern about false reassurance ifthe test is not
100% specific (and, so far, no screening test
has this attribute). There also are legitimate
concerns about the effects of labeling,
especially iferadication ofthe risk ofa rele-
vant cancer cannot be guaranteed. Thus,
genetic screening can only be justified as
part of a defined research protocol, and
only when both costs and benefits are eval-
uated. Such protocols initially must con-
centrate on those identified to be at high
risk through nongenetic means. We eventu-
allywill have to face whether to extend such
research into that important segment ofthe
population that currently is not regarded to
be at high risk but in whom currently the
majority of cancers occur.
Avoidable Cancers Based
on Current Knowledge
We must quantify the size ofthe problem,
assess results ofinterventions, and maintain
high-quality surveillance systems. Poverty
(lack of education) can be regarded as a
carcinogen, although it is not always advan-
tageous to be rich. Dispersion theory recog-
nizes that some habits are taken up first by
the rich and then by the poor, as exhibited
by the changing social class risks for lung
cancer and the diet-associated cancers.
The list of avoidable cancers is long,
headed by lung but closely followed by the
other tobacco-associated cancers (orophar-
ynx, larynx, esophagus, pancreas, bladder,
kidney, and perhaps, cervix) and the diet-
associated cancers (breast, colon, prostate,
stomach, rectum, and pancreas, as well as
lung and bladder). The overlap between
these lists emphasizes both the interaction
between different factors and the fact that
the proportion of cancer attributable, and
even more so the proportion attributable to
individual factors, is controversial, although
we have to bear in mind the time it takes
to have full impact on the population.
However, if the cancers caused by alcohol
and known occupational hazards and sun-
light are added, it seems clear that current
knowledge theoretically permits avoidance
ofover 50% ofour current cancer burden,
ifnot more.
If it is preventable, why is it not pre-
vented? The major gap in our knowledge is
not about causes of cancer on which we
can intervene now but the difficulty in
achieving any impact on deeply ingrained
lifestyle and cultural factors. Research into
this area, as identified above, has very high
priority for a number offactors.
Needsfor the Future
For cancer prevention, a cautionary princi-
ple is in order: "Try not to do things that
have unwelcome consequences. We do not
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want to be wrong too far in the wrong
direction," i.e., prudent avoidance. For
ionizing radiation, the as low as reasonably
achievable (ALARA) principle is well
accepted. For tobacco smoking, zero expo-
sure is the legitimate goal, but for many
other known or suspect carcinogens,
the ALARA principle may be the only
appropriate, ifnot acceptable, approach.
We need new tools for exposure assess-
ment, new approaches for studying com-
plex mixtures, improved surveillance
methods, and more qualified investigators
who are able to combine biology with
epidemiology in a collaborative multidisci-
plinary mode. However, the main need at
present is to evaluate the success ofwhat is
being done, and in accordance with the
measurement-iterative loop principle,
increase the effectiveness and efficiency of
the interventions that are applied to the
general population.
Government has a role, and it is impor-
tant to ensure consistency of policies,
which clearly is not the case for tobacco,
and possibly not for diet and other factors.
This is partly a need for public health
policy research, but also partly a function
ofeffective leadership at the highest and at
the cabinet levels. If government really
wishes to promote human health, it should
demonstrate to the public that it is serious,
and carefully evaluate the health conse-
quences ofall government actions as well
as the economic consequences. Ifeconomic
factors predominate, the government
should make this clear; ifpolitical, as in the
tobacco taxation issue, this should also be
made explicit. Then the public will be able
to decide whether their representatives are
carrying out their mandate in accordance
with their wishes and act accordingly.
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